<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="32717" whole_study_id="11364" phs="000807" v="2" createDate="2019-01-03T10:36:47-05:00" completedByGPADate="2019-05-07T10:08:24-05:00" modDate="2019-05-07T10:08:24-05:00" maxParentChildStudyModDate="2019-05-07T10:08:24-05:00" handle="CALGB40101_BreastCancer" num_participants="1916"><StudyInfo accession="phs000807.v2" parentAccession="phs000807.v2"><BioProject id="PRJNA262702" entrez_id="262702" type="bp_admin_access"/><BioProject id="PRJNA262703" entrez_id="262703" type="bp_data_submission"/><StudyNameEntrez>PGRN-RIKEN-CALGB 40101 - Genome-wide Pharmacogenomic Study of Cyclophosphamide, Doxorubicin and Paclitaxel in Breast Cancer</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>germline</StudyType><StudyType>snp_array</StudyType></StudyTypes><Funding>U19 GM061390</Funding></StudyInfo><Authority><ICs><IC id="1" name="NIGMS" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="KROETZ" aid="2" auth="eRA" login="KROETZ" fname="Deanna" mname="L" lname="Kroetz" email="deanna.kroetz@ucsf.edu"><Role>PI</Role><Organization>GORDON RESEARCH CONFERENCESUNIVERSITY OF CALIFORNIA, SAN FRANCISCO</Organization></Person><Person nedid="KOWZAR" aid="2" auth="eRA" login="KOWZAR" fname="Kouros" lname="Owzar" email="kouros.owzar@duke.edu"><Role>PI_ASSIST</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010150228" aid="1" auth="cit" login="dkras" fname="Donna" mname="M" lname="Krasnewich-Vostal" email="dkras@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The investigators request that the following papers are formally acknowledged:   

Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, Ritchie MD, Plenge RM, Witte JS, Kroetz DL. Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). Pharmacogenomics J. 2014 Feb 11. doi: 10.1038/tpj.2014.2. PMID: 24513692     

Wheeler HE, Gamazon ER, Wing C, Njiaju UO, Njoku C, Baldwin RM, Owzar K, Jiang C, Watson D, Shterev I, Kubo M, Zembutsu H, Winer EP, Hudis CA, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL; Cancer and Leukemia Group B, Cox NJ, Dolan ME.  Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res. 2013 Jan 15;19(2):491-9. doi: 10.1158/1078-0432.CCR-12-2618. Epub 2012 Nov 30. PMID: 23204130       

Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, Martino S, Atkins JN, Mayer E, Schneider CJ, Kimmick G, Norton L, Muss H, Winer EP, Hudis C. Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. J Clin Oncol. 2012 Nov 20;30(33):4071-6. doi: 10.1200/JCO.2011.40.6405. Epub 2012 Jul 23. PMCID: PMC3494835       

Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res. 2012 Sep 15;18(18):5099-109.  PMID: 22843789 
</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_old_cert" gsr_mode_label="Unrestricted access (institution responded that the study is not sensitive without submitting a new Institutional Certification)"/><ConsentGroup uid="1231" CGType="cg_class_other" title="For the use in future research to learn about, prevent or treat cancer" name="APTC" dac_uid="58" dac_name="NIGMS" irb-approval-required="No"><Use-Restriction>Data may be used only for genetic studies to learn about, prevent or treat cancer.  Investigators must state in their DAR their intention to publish or otherwise broadly share any findings from their study with the scientific community.  </Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="14" name="completed_by_gpa" title="Completed by GPA"/></Study><Study uid="11364" whole_study_id="11364" phs="000807" v="1" p="1" createDate="2014-05-12T13:04:42-05:00" completedByGPADate="2014-05-12T15:23:12-05:00" modDate="2020-09-01T10:33:20-05:00" maxParentChildStudyModDate="2020-09-01T10:33:20-05:00" handle="CALGB40101_BreastCancer" num_participants="1916"><StudyInfo accession="phs000807.v1.p1" parentAccession="phs000807.v1.p1"><BioProject id="PRJNA262702" entrez_id="262702" type="bp_admin_access"/><BioProject id="PRJNA262703" entrez_id="262703" type="bp_data_submission"/><StudyNameEntrez>PGRN-RIKEN-CALGB 40101 - Genome-wide Pharmacogenomic Study of Cyclophosphamide, Doxorubicin and Paclitaxel in Breast Cancer</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="Yes"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="No"/><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="Yes"><StudyType22 name="array_multi_sample_gen"/></StudyType21><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="germline"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>phenotype_data</StudyType><StudyType>genotype_data</StudyType><StudyType>germline</StudyType><StudyType>snp_array</StudyType></StudyTypes><Funding>U19 GM061390</Funding></StudyInfo><Authority><ICs><IC id="1" name="NIGMS" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="KROETZ" aid="2" auth="eRA" login="KROETZ" fname="Deanna" mname="L" lname="Kroetz" email="deanna.kroetz@ucsf.edu"><Role>PI</Role><Organization>GORDON RESEARCH CONFERENCESUNIVERSITY OF CALIFORNIA, SAN FRANCISCO</Organization></Person><Person nedid="KOWZAR" aid="2" auth="eRA" login="KOWZAR" fname="Kouros" lname="Owzar" email="kouros.owzar@duke.edu"><Role>PI_ASSIST</Role><Organization>DUKE UNIVERSITY</Organization></Person><Person nedid="0012988688" aid="1" auth="cit" login="popovan" fname="Natalia" mname="V" lname="Popova" email="popovan@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010150228" aid="1" auth="cit" login="dkras" fname="Donna" mname="M" lname="Krasnewich-Vostal" email="dkras@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="12 months"><acknowledgement_statement>The investigators request that the following papers are formally acknowledged:   

Chhibber A, Mefford J, Stahl EA, Pendergrass SA, Baldwin RM, Owzar K, Li M, Winer EP, Hudis CA, Zembutsu H, Kubo M, Nakamura Y, McLeod HL, Ratain MJ, Shulman LN, Ritchie MD, Plenge RM, Witte JS, Kroetz DL. Polygenic inheritance of paclitaxel-induced sensory peripheral neuropathy driven by axon outgrowth gene sets in CALGB 40101 (Alliance). Pharmacogenomics J. 2014 Feb 11. doi: 10.1038/tpj.2014.2. PMID: 24513692     

Wheeler HE, Gamazon ER, Wing C, Njiaju UO, Njoku C, Baldwin RM, Owzar K, Jiang C, Watson D, Shterev I, Kubo M, Zembutsu H, Winer EP, Hudis CA, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL; Cancer and Leukemia Group B, Cox NJ, Dolan ME.  Integration of cell line and clinical trial genome-wide analyses supports a polygenic architecture of Paclitaxel-induced sensory peripheral neuropathy. Clin Cancer Res. 2013 Jan 15;19(2):491-9. doi: 10.1158/1078-0432.CCR-12-2618. Epub 2012 Nov 30. PMID: 23204130       

Shulman LN, Cirrincione CT, Berry DA, Becker HP, Perez EA, O'Regan R, Martino S, Atkins JN, Mayer E, Schneider CJ, Kimmick G, Norton L, Muss H, Winer EP, Hudis C. Six cycles of doxorubicin and cyclophosphamide or Paclitaxel are not superior to four cycles as adjuvant chemotherapy for breast cancer in women with zero to three positive axillary nodes: Cancer and Leukemia Group B 40101. J Clin Oncol. 2012 Nov 20;30(33):4071-6. doi: 10.1200/JCO.2011.40.6405. Epub 2012 Jul 23. PMCID: PMC3494835       

Baldwin RM, Owzar K, Zembutsu H, Chhibber A, Kubo M, Jiang C, Watson D, Eclov RJ, Mefford J, McLeod HL, Friedman PN, Hudis CA, Winer EP, Jorgenson EM, Witte JS, Shulman LN, Nakamura Y, Ratain MJ, Kroetz DL. A genome-wide association study identifies novel loci for paclitaxel-induced sensory peripheral neuropathy in CALGB 40101. Clin Cancer Res. 2012 Sep 15;18(18):5099-109.  PMID: 22843789 
</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="1231" CGType="cg_class_other" title="For the use in future research to learn about, prevent or treat cancer" name="APTC" dac_uid="58" dac_name="NIGMS" irb-approval-required="No"><Use-Restriction>Data may be used only for genetic studies to learn about, prevent or treat cancer.  Investigators must state in their DAR their intention to publish or otherwise broadly share any findings from their study with the scientific community.  </Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>